Table of Contents
Once again, the drugs Big Pharma swore were "safe and effective" have been unmasked as ticking time bombs, sparking a deadly decline that could claim women's lives and futures.
Depo-Provera, the shot pushed on one in four sexually active American women, now stands exposed for doubling the risk of brain tumors, fueling a firestorm of over 1,200 lawsuits against Pfizer.
A bombshell study in JAMA Neurology, analyzing 61 million female patient records from Cleveland Clinic and Case Western Reserve University researchers, delivers the gut punch: Women on depot medroxyprogesterone acetate —Depo-Provera's synthetic progestin hormone that halts ovulation for three months—face twice the odds of meningioma diagnosis versus those off hormonal birth control.
These slow-growing tumors, mostly benign but brutal, crush nerves and brain tissue, striking women hardest due to hormone-fueled growth.
Risk skyrockets for those starting after age 31 or using it for four-plus years.
"In this study, women receiving DMPA had a greater relative risk of subsequent meningioma diagnosis, especially with prolonged exposures and starting the medication at older ages,” the authors blasted in their report.
This observational juggernaut echoes a 2023 BMJ French study that uncovered one year-plus of Depo-Provera spikes meningioma risk 5.6-fold.
Synthesized in 1954 for endometriosis and fibroids, the FDA stonewalled Depo-Provera's approval until 1992 over cancer fears, but greenlighted the contraceptive after global use.
A 2004 black box warning screamed bone density loss from long-term jabs.
Studies linking progesterone to meningioma date to 1983, yet Pfizer sat idle.
Now, fury erupts in federal courts.
Louisiana plaintiff Robin Phillip, blinded in her left eye and hobbling from an intracranial meningioma, leads the charge.
Her suit blasts Pfizer for ignoring decades-old red flags.
"These women all have meningiomas. Many have surgery, some have radiation, and they’ve all had their lives greatly impacted," attorney Ellen Relkin warned in a statement to NBC News.
A Pfizer rep insists, "These claims are without merit and [Pfizer] will vigorously defend against these allegations," noting the pharmaceutical giant "stands behind the safety and efficacy of Depo-Provera, which has been used by millions of women worldwide and remains an important treatment option for women seeking to manage their reproductive health."
The company motioned to dismiss in August, bragging of its 2023 "discovery" of the link—and an FDA label update request shot down for "insufficient evidence."
This is the corporate scheme OBGYNs peddle at every checkup, a total scam.
"Birth control" to shield from babies?
It's poisoning wombs and brains, with U.S. infertility rates exploding as these shots sabotage fertility long-term, while birthing brain tumors that steal sight, steps, and sanity.
Conversation